PROGRAMME
08:00 - 08:45:00: Registration & Breakfast
SESSION ONE
Moderators:
Prof. Hany Zayed, Guy's & St. Thomas' NHS Foundation Trust
Prof. Mo Hamady, Imperial College Healthcare NHS Trust
Mr. Said Abisi, Guy's & St. Thomas' NHS Foundation Trust
08:45 – 08:50: Welcome
08:50 – 08:58: Covered vs Uncovered Stenting of Aorto-Iliac Occlusive Disease: Long-Term Outcomes from the European COBRA Registry
Mr Arsalan Wafi, Guy's & St. Thomas' NHS Foundation Trust
08:58 – 09:06: Management of Coral-Reef Aorto-Iliac Disease: Is There a Role for Endovascular Therapy?
Dr Konstantinos Stavroulakis, Klinikum Hochsauerland, Arnsberg
09:06 – 09:14: Aorto-iliac IVL's emerging role in renal transplantation: from securing inflow to preparing the implantation site
Mr Rashid Akhtar, The Royal London & St Barts Hospitals, Barts Health NHS Trust and The London Clinic
09:14 – 09:19: Industry talk – Shockwave
Details TBC
09:19 – 09:35: Q&A
TASC C & D Aorto-Iliac Disease – Debate:
09:35 – 09:43: Why CERAB Is My First Choice
Prof Michel Reijnen, Rijnstate Hospital, Arnhem
09:43 – 09:51: Why Surgery Should Be the First Choice
Mr Sanjay Patel, Guy's and St Thomas' NHS Foundation Trust
09:51 – 09:59: Haemodynamic Impact of Stenting Across the Femoral Bifurcation
Mr Adam Geale, King's College, London
09:59 – 10:07: Real-World Outcomes from the SAVE-CFA European Registry
Dr Bahaa Nasr, Hospital Center Regional University Morvan De Brest, France
10:07 – 10:25: Q&A
10:25 – 10:55: Morning Networking & Refreshment Break
SESSION TWO
Moderators:
Dr. Tarun Sabharwal, Guy's & St. Thomas' NHS Foundation Trust
Prof. Miltiadis Krokidis, Areteion University Hospital
Mr. Morad Sallam, Guy's & St. Thomas' NHS Foundation Trust
10:55 – 11:00: Industry Talk – Abbott
Details TBC
11:00 – 11:08: Drug Elution in the Femoropopliteal Segment: Paclitaxel Remains the First Choice
Prof Yann Gouëffic, Groupe Hospitalier Paris Saint Joseph Paris, France
11:08 – 11:16: Drug Elution in the Femoropopliteal Segment: Limus-Based Technology Should Be First Choice
Dr Sabine Steiner, University Hospital Leipzig
11:16 – 11:24: Drug Elution in the Femoropopliteal Segment: No Clinical or Cost Benefit
Mr Matt Popplewell, The Royal Wolverhampton Trust / University of Birmingham
11:24 – 11:32: Dynamic Risk of Death with Paclitaxel coated devices
Dr Konstantinos Katsanos, Patras University Hospital, Rion
11:32 – 11:45: Q&A
11:45 – 11:55: Industry Talk – Boston Scientific
Details TBC
11:55 – 12:03: What is vessel preparation? And why?
Prof Giovanni Torsello, St. Franziskus Hospital, Munster, Germany
12:03 – 12:11: Vessel preparation tools: Choosing the right device for the right lesion
Prof Stavros Spilliopoulos, National and Kapodistrian University of Athens, Greece
12:11 – 12:19: Emerging and promising Vessel Preparation Technologies
Dr Marianne Brodmann, Med Uni, Graz
12:19 – 12:27: PAD Research Update: Ongoing and new RCTs
Prof. Athanasios Saratzis, NIHR Leicester Biomedical Research Centre
12:27 – 12:35: The hidden population in vascular research
Prof. Isabelle Van Herzeele, Ghent University Hospital
12:35 – 12:45: Driving change: delivering reform through collaboration
Mr Roger Greer, HealthTech/MedTech & Digital Health
12:45 – 13:05: Q&A
13:05 – 14:05: Lunch & Networking
SESSION THREE
Moderators:
Miss. Kaji Sritharan, York & Scarborough Teaching Hospitals NHS Foundation Trust
Dr. Panos Gkoutzios, Guy's & St. Thomas' NHS Foundation Trust
Mr. Patrick Chong, Surrey Heart, Stroke and Vascular Centre
14:05 – 14:20: LIVE CASE TRANSMISSION
14:20 – 14:25: Industry Talk – Gore
Details TBC
14:25 – 14:33: Treating Popliteal Artery Aneurysms: Results from the European PARADE Registry
Prof Nicola Troisi, University of Pisa
14:33 – 14:41: New Tools to Manage Tibial Calcification
Prof Andrej Schmidt, University of Leipzig
14:41 – 14:49: Retrograde tibio-pedal access: Beginner's Manual
Dr Lorenzo Patrone, San Giovanni di Dio Hospital Florence, Italy
14:49 – 14:57: Below-the-Ankle Interventions: Not for the Faint-Hearted
Dr Sapna Puppala, Leeds Teaching Hospitals NHS Foundation Trust
14:57 – 15:05: Anti-Thrombotictherapy following lower limb revascularisation: Do we need some CLARITY here?
Mr Chris Twine, North Bristol NHS Trust
15:05 – 15:13: BEST in management of Peripheral AVM
Dr Tarun Sabharwal, Guy's & St. Thomas' NHS Foundation Trust
15:13 – 15:30 – Q&A
15:30 – 15:45: LIVE CASE TRANSMISSION
15:45 – 15:53: Drug Delivery Below the Knee: Why Have We Failed and What Comes Next?
Dr Katherine Lewis, Somerset NHS Foundation Trust
15:53 – 16:01: Imaging of CLTI: From Anatomy to Perfusion
Dr Conrad von Stempel, UCLH and Royal Free Hospitals
16:01 – 16:09: Local Antibiotic Delivery in CLTI: Effective Strategy or Hype?
Dr Prash Vas, King's College Hospital NHS Foundation Trust
16:09 – 16:17: Mid-Term Outcomes of Percutaneous Deep Venous Arterialisation
Mr Ahmed Morshed, Locum Vascular & Endovascular Surgery Consultant, Sheffield Teaching Hospitals
16:17 – 16:25: Predicting Outcomes After pDVA Using a Novel Classification System
Dr Narayanan Thulasidasan, Guy's and St Thomas' NHS Foundation Trust
16:25 – 16:30: Industry Talk – Bentley
Details TBC
16:30 – 16:45: Q&A
16:45 – 17:15: Afternoon Refreshments & Networking Break
SESSION FOUR: Nightmare Cases - Complications, Bailouts, and Lessons Learned
Moderators:
Dr. Tarun Sabharwal, Guy's & St. Thomas' NHS Foundation Trust
Mr Prakash Saha, Guy's & St. Thomas' NHS Foundation Trust
Dr. Anthanasios Diamantopoulos, Guy's & St. Thomas' NHS Foundation Trust
17:15 – 17:23: My Nightmare Case
Prof Andrej Schmidt, University of Leipzig
17:23 – 17:31: My Nightmare Case
Dr Hossam Saro, Guy's and St Thomas' NHS Foundation Trust
17:31 – 17:39: My Nightmare Case
Mr Junjie Ng, Guy's and St Thomas' NHS Foundation Trust
17:39 – 17:47: My Nightmare Case
Dr Amrin Israrahmed, Guy's and St Thomas' NHS Foundation Trust
17:47 – 17:55: My Nightmare Case
Dr Bahaa Nasr, Hospital Center Regional University Morvan De Brest, France
17:55 – 18:03: My Nightmare Case
Dr Kerbi Guevara-Noriega, Guy's and St Thomas' NHS Foundation Trust
18:03 – 18:20: Q&A
18:20 – 18:30: Closing comments
18:30 – 20:00: The STARS Reception. Drinks, bowl food & networking